Condition (MeSH)
Gitelman Syndrome
ClinicalTrials.gov lists 6 trials for Gitelman Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 6 trials are tagged with Gitelman Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Gitelman Syndrome trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 2 |
| 2014 | 1 |
| 2010 | 1 |
| 2009 | 2 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 6 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Gitelman Syndrome trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 4 | 1 |
| Not applicable | 2 |
| Observational | 2 |
How many Gitelman Syndrome trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Gitelman Syndrome? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Adrenal adaptation in potassium-depleted men: role of progesterone? | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2020 | Yes |
| Systems biology of diuretic resistance. | The Journal of clinical investigation | 2015 | Yes |
| Abnormal glucose metabolism and insulin sensitivity in Chinese patients with Gitelman syndrome. | American journal of nephrology | 2013 | Yes |
| Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2009 | Yes |
| A thiazide test for the diagnosis of renal tubular hypokalemic disorders. | Clinical journal of the American Society of Nephrology : CJASN | 2007 | Yes |
Showing 5 of 6 publications.
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Gitelman syndrome | Point prevalence | 1-9 / 100 000 | Europe | Not stated | Exact |
| Gitelman syndrome | Point prevalence | 1-9 / 100 000 | Europe | Not stated | Unspecified |
| Gitelman syndrome | Point prevalence | 1-9 / 100 000 | Europe | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Gitelman syndrome | 358 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Gitelman syndrome | 358 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.